Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.

← Back to Medmonitor

Medication Type: Allergic Reaction

Allergic Reaction

Neffy^® (epinephrine nasal spray)

Approval Date: Aug 2024

Note: New Product

Indicated for the emergency treatment of type I allergic reactions, including anaphylaxis

Medication Name

Approval Date

Category

Description

Neffy^® (epinephrine nasal spray)

Aug 2024

Allergic Reaction

Indicated for the emergency treatment of type I allergic reactions, including anaphylaxis

Note: New Product

Workers' Comp Property and Casualty PBM
Expires 01/01/2028